Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Clinicopathologic significance of nuclear grooves and inclusions in renal cell carcinoma: image database construction and quantitative scoring.

Lee JH, Han EM, Lin ZH, Wu ZS, Lee ES, Kim YS.

Arch Pathol Lab Med. 2008 Jun;132(6):940-6. doi: 10.1043/1543-2165(2008)132[940:CSONGA]2.0.CO;2.

PMID:
18517276
2.

Prognostic value of capsular invasion for localized clear-cell renal cell carcinoma.

Cho HJ, Kim SJ, Ha US, Hong SH, Kim JC, Choi YJ, Hwang TK.

Eur Urol. 2009 Dec;56(6):1006-12. doi: 10.1016/j.eururo.2008.11.031. Epub 2008 Nov 28.

PMID:
19135776
3.

Computerized nuclear morphometry: prognostic value for carcinoma of the prostate and renal cell carcinoma.

Wenderoth UK, Gerlach B, Köppen A, Hautmann RE.

Investig Urol (Berl). 1994;5:16-9. No abstract available.

PMID:
7719300
4.

Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.

Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS.

Am J Surg Pathol. 1997 Jun;21(6):621-35.

PMID:
9199639
5.

Nuclear quantitative grading by discriminant analysis of renal cell carcinoma samples. A patient survival evaluation.

Artacho-Pérula E, Roldán-Villalobos R, Martínez-Cuevas JF, López-Rubio F.

J Pathol. 1994 Jun;173(2):105-14.

PMID:
8089804
6.

Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study.

Lee WK, Byun SS, Kim HH, Rha KH, Hwang TK, Sung GT, Lee W, Lim JS, Jeong YB, Kwon TG.

Int J Urol. 2010 Nov;17(11):898-904. doi: 10.1111/j.1442-2042.2010.02630.x. Epub 2010 Oct 4.

7.

Stage I renal cell carcinoma. A clinicopathologic study of 82 cases.

Gelb AB, Shibuya RB, Weiss LM, Medeiros LJ.

Am J Surg Pathol. 1993 Mar;17(3):275-86.

PMID:
8434708
8.

Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?

Ficarra V, Novara G, Galfano A, Novella G, Schiavone D, Artibani W.

Urology. 2004 Jun;63(6):1050-4.

PMID:
15183948
9.

Value of volume weighted mean nuclear volume in grading and prognosis of renal cell carcinoma.

Artacho-Pérula E, Roldán-Villalobos R, Martínez-Cuevas JF.

J Clin Pathol. 1994 Apr;47(4):324-8.

10.

Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.

Krejci KG, Blute ML, Cheville JC, Sebo TJ, Lohse CM, Zincke H.

Urology. 2003 Oct;62(4):641-6. Review.

PMID:
14550434
11.

Tumor heterogeneity as prognostic factor in patients with low-stage (T1-3N0M0) renal-cell carcinoma.

van der Poel HG, Mulders PF, Oosterhof GO, Schaafsma HE, Hendriks JC, Schalken JA, Debruyne FM.

Investig Urol (Berl). 1994;5:60-5. No abstract available.

PMID:
7719322
12.

Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.

Jung EJ, Lee HJ, Kwak C, Ku JH, Moon KC.

Urology. 2009 Jan;73(1):137-41. doi: 10.1016/j.urology.2008.08.460. Epub 2008 Oct 31.

PMID:
18950844
13.

Prognosis of renal cell carcinoma related to nuclear grade, DNA content and Robson stage.

Klöppel G, Knöfel WT, Baisch H, Otto U.

Eur Urol. 1986;12(6):426-31.

PMID:
3816899
14.

Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneity.

van der Poel HG, Mulders PF, Oosterhof GO, Schaafsma HE, Hendriks JC, Schalken JA, Debruyne FM.

Cancer. 1993 Nov 1;72(9):2667-74.

15.

A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.

Sun M, Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Arjane P, Widmer H, Pharand D, Latour M, Perrotte P, Patard JJ, Karakiewicz PI.

Eur Urol. 2009 Nov;56(5):775-81. doi: 10.1016/j.eururo.2009.06.008. Epub 2009 Jun 21.

PMID:
19573980
16.

Impact of lymph node invasion and sarcomatoid differentiation on the survival of patients with locally advanced renal cell carcinoma.

Rodríguez-Covarrubias F, Castillejos-Molina R, Sotomayor M, Méndez-Probst CE, Gómez-Alvarado MO, Uribe-Uribe N, Gabilondo F, Feria-Bernal G.

Urol Int. 2010;85(1):23-9. doi: 10.1159/000318994. Epub 2010 Jul 26.

PMID:
20693824
17.
18.

[Survival in non-metastatic clear-cell renal cancer].

Iurin AG.

Vopr Onkol. 2010;56(1):50-4. Russian.

PMID:
20361615
19.

Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma.

Hong SK, Jeong CW, Park JH, Kim HS, Kwak C, Choe G, Kim HH, Lee SE.

BJU Int. 2011 Feb;107(3):409-15. doi: 10.1111/j.1464-410X.2010.09561.x. Epub 2010 Aug 26.

20.

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.

Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A.

J Urol. 2000 Apr;163(4):1090-5; quiz 1295.

PMID:
10737472

Supplemental Content

Support Center